论文部分内容阅读
目的：研究分析老年重症心力衰竭临床内科治疗的效果。方法：选取我院2013年5月至2014年5月收治的76例老年重症心力衰竭患者，随机分为对照组和观察组，每组各38例，给予对照组常规药物治疗，给予观察组在常规治疗的基础上使用厄贝沙坦氢氯噻嗪片联合美托洛尔治疗，观察两组患者的治疗效果。结果：所有患者通过治疗后，观察组患者治疗的总有效率为94．7％，对照组患者治疗的总有效率为78．9％，观察组患者的治疗效果明显优于对照组，差异显著（P＜0．05），具有统计学意义。结论：针对老年重症心力衰竭的患者，在常规治疗的基础上，使用厄贝沙坦氢氯噻嗪片联合美托洛尔治疗，可以有效的提高患者的治疗效果，有利于改善患者的心功能情况，在提高患者的生活质量方面具有较大的积极作用，值得临床推广使用。
Objective: To study the effect of clinical medical treatment on senile severe heart failure. Methods: A total of 76 elderly patients with severe heart failure who were admitted to our hospital from May 2013 to May 2014 were randomly divided into control group and observation group, with 38 patients in each group. The patients in control group were given conventional drug treatment and the patients in observation group were treated with The conventional treatment based on the use of irbesartan hydrochlorothiazide tablets combined with metoprolol treatment was observed in two groups of patients with treatment. Results: After all patients were treated, the total effective rate of treatment in observation group was 94.7%, while that in control group was 78.9%. The treatment effect in observation group was significantly better than that in control group (P <0.05), with statistical significance. Conclusion: The treatment of senile patients with severe heart failure on the basis of routine treatment with irbesartan hydrochlorothiazide tablets combined with metoprolol can effectively improve the therapeutic effect of patients, which is beneficial to improve the patient’s cardiac function. Improve the quality of life of patients with a greater positive role, it is worth to promote clinical use.